ARIEL SCIENTIFIC INNOVATIONS LTD.

Methods for treating solid or semi-solid waste (sludge, litter, industrial byproducts) from water treatment processes, often with a focus on reducing volume, detoxifying, or recovering valuable resources like energy (biogas), chemicals, or materials.

Membrane-based separation for water purification, contaminant removal, desalination, and wastewater treatment, including reverse osmosis, ultrafiltration, and forward osmosis modules.

Catalytic processes and novel catalyst materials designed to efficiently produce hydrogen gas from various feedstocks, including hydrocarbons (e.g., methane, natural gas) and ammonia.

Systems and methods for electronically steering or shaping antenna beams by controlling the phase and amplitude of signals fed to individual elements in an array, including calibration techniques and multi-antenna configurations.

Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.

Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.

Methods and systems for the efficient and scalable production, purification, and formulation of proteins and peptides, including fermentation, chromatography, and cell-based expression systems.

Methods and systems for efficiently reducing the size of digital data, often employing adaptive techniques, neural networks, or temporal modeling, to achieve high compression ratios while preserving data quality. Includes entropy coding.

Utilizing magnetic fields or magnetic particles (nanoparticles, nanofiber membranes) to attract, bind, and remove pollutants or facilitate the separation of components from water or fluid mixtures.

Technologies enabling dynamic control over electromagnetic wave propagation using arrays of passive or active elements (unit cells) to reflect, refract, or absorb signals, often for channel optimization or energy efficiency.

Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.

Focuses on novel circuit configurations for DC-DC, DC-AC, or AC-DC conversion, often involving resonant operation, multi-level structures, or switched capacitors to improve efficiency, power density, or voltage conversion ratios.

Technologies and materials for capturing carbon dioxide from gas streams and subsequently converting it into valuable chemical products or materials, rather than simply storing it.

Development of catalytic materials and membrane electrode assemblies (MEAs) specifically designed for the electrochemical reduction of carbon dioxide (CO2) or carbon monoxide (COx) into valuable chemicals or fuels.

Utilization of electrochemical processes to synthesize a variety of chemical products, materials, or to treat waste streams, by selectively promoting redox reactions of specific feedstocks beyond hydrogen or CO2 reduction.

Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.

Development and application of therapeutic proteins or peptides produced through recombinant DNA technology, including fusion proteins and modified growth factors.

Development of encoding and decoding algorithms and apparatuses for robust data transmission and storage, focusing on techniques like LDPC, polar codes, and iterative decoding methods to minimize bit errors and improve communication reliability.

Integration of power converters with energy storage devices (batteries, supercapacitors) or grid interfaces, often involving AC/DC conversion, power flow management, and fault handling for hybrid power systems or specific applications like EVs or PV.

Methods and systems for enhancing the operational lifespan, stability, and performance management of electrolyzers, including strategies for preventing degradation, restoring activity, and regulating operating conditions.

Therapeutic strategies employing nucleic acids (DNA, RNA, oligonucleotides) to modulate gene expression, deliver genetic material, or interfere with disease-causing pathways. Includes gene therapy using viral vectors.

Methods and apparatus for the efficient and selective production of organic compounds, including amines, acids, and esters, often involving catalytic or continuous processes and purification steps.

Techniques and structures used to reduce unwanted electromagnetic coupling, scattering, or interference between multiple antennas, different frequency bands, or sensitive electronic components within a device.